David Hallal - 10 Mar 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role: Director, 10%+ Owner
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: ALVR
Transactions as of: 10 Mar 2022
Net transactions value: -$491,850
Form type: 4
Filing time: 11 Mar 2022, 18:14:59 UTC
Previous filing: 25 Jan 2022
Next filing: 22 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Sale	$305,781	-40,481	-1.8%	$7.55	2,173,085	10 Mar 2022	Direct	F1, F2
transaction	ALVR	Common Stock	Sale	$186,068	-25,244	-1.2%	$7.37	2,147,841	11 Mar 2022	Direct	F1, F3
holding	ALVR	Common Stock						13,420,970	10 Mar 2022	See Footnote	F4
holding	ALVR	Common Stock						1,120,965	10 Mar 2022	See Footnote	F5
holding	ALVR	Common Stock						738,153	10 Mar 2022	See Footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 7, 2022 to cover tax withholding obligations upon the vesting and settlement of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.27 to $7.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.18 to $7.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
F4	Shares held by ElevateBio LLC ("ElevateBio"). The Reporting Person is the Chairman and Chief Executive Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F5	Shares held by The Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F6	Shares held by Terrie A. Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.